for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Ablynx achieves first milestone in collaboration with Novo Nordisk

Nov 30 (Reuters) - Ablynx NV :

* Ablynx achieves first milestone as part of collaboration with Novo Nordisk

* Ablynx to receive 1 million euro ($1.06 million) success fee

* Ablynx received an upfront license fee of 5 million euros and will receive up to 4 million euros in research funding during the initial three year research term of the collaboration

* Ablynx is eligible to receive potential development, regulatory and commercial milestone payments of up to 182 million euros plus tiered royalties on the annual net sales Source text for Eikon: Further company coverage: ($1 = 0.9409 euros) (Gdynia Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up